Ulinastatin ameliorates the malignant progression of prostate cancer cells by blocking the RhoA/ROCK/NLRP3 pathway-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Ulinastatin ameliorates the malignant progression of prostate cancer cells by blocking the RhoA/ROCK/NLRP3 pathway

Published:2022-12-02 Issue:1 Volume:84 Page:36-44
ISSN:0272-4391
Container-title:Drug Development Research
language:en
Short-container-title:Drug Development Research

Author:

Liu Zhiguang¹,Zhu Xiaochun¹,Xu Chenglin¹,Min Feng¹,Yu Guofeng²^ORCID,Chen Chuhong³

Affiliation:

1. Department of Urology Guangming Traditional Chinese Medicine Hospital of Pudong New Area Shanghai China

2. Department of Urology, Jinshan Branch of Shanghai Sixth People's Hospital Shanghai Jiaotong University Shanghai China

3. Department of Urology, Shanghai Pudong Hospital Fudan University Pudong Medical Center Shanghai China

Publisher

Wiley

Subject

Drug Discovery

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ddr.22010

Reference30 articles.

1. The role of the RhoA/Rho kinase pathway in angiogenesis and its potential value in prostate cancer (Review)

2. Early local drug therapy for pancreatic contusion and laceration

3. Protective effects of ulinastatin on pancreatic and renal damage in rats following early scald injury

4. Ulinastatin Exerts Synergistic Effects with Taxotere and Inhibits Invasion and Metastasis of Breast Cancer by Blocking Angiogenesis and the Epithelial–Mesenchymal Transition

5. Annual report to the nation on the status of cancer, part I: National cancer statistics

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Caspase-Linked Programmed Cell Death in Prostate Cancer: From Apoptosis, Necroptosis, and Pyroptosis to PANoptosis;Biomolecules;2023-11-28

2. Exploring the role of the inflammasomes on prostate cancer: Interplay with obesity;Reviews in Endocrine and Metabolic Disorders;2023-10-11

3. Nafamostat mesilate prevented caerulein-induced pancreatic injury by targeting HDAC6-mediated NLRP3 inflammasome activation;Inflammation Research;2023-09

4. Optimization of Neferine Purification Based on Response Surface Methodology and Its Anti-Metastasis Mechanism on HepG2 Cells;Molecules;2023-06-29

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3